Funded Symptom Science Grants

Active/Completed

Topics

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Ross, Stephen	New York University School Of Medicine United States	Psilocybin Therapy for Advanced Cancer-related Psychiatric Distress	5R01CA268521-04	Rachel Altshuler, Ph.D.
Roth, Michael E.	Public Health Institute United States	Children's Oncology Group NCI Community Oncology Research Program (NCORP) Research Base grant	3UG1CA189955-11S2	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Roth, Michael E.	Public Health Institute United States	Children's Oncology Group NCI Community Oncology Research Program (NCORP) Research Base grant	3UG1CA189955-11S2	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Rowland, Kendrith Martin	Carle Foundation United States	Carle Cancer Center NCI Community Oncology Research Program (NCORP)	5UG1CA189861-11	Vanessa A. White, M.P.H.
Rowland, Kendrith Martin	Carle Foundation United States	Carle Cancer Center NCI Community Oncology Research Program (NCORP)	5UG1CA189861-11	Vanessa A. White, M.P.H.
Russell, John A	University Of Wisconsin-Madison United States	Treatment of Functional Deficits IN tongue muscles induced by radiation and chemoradiation treatment	5R37CA225608-07	Cecilia Lee, Dr.P.H., RN
Russell, John A	University Of Wisconsin-Madison United States	Treatment of Functional Deficits IN tongue muscles induced by radiation and chemoradiation treatment	5R37CA225608-07	Cecilia Lee, Dr.P.H., RN
Salman, Emad	Florida Assn Of Pediatric Tumor Prog United States	The Florida Pediatric NCORP renewal application for grant# UG1CA189973 to continue participation in the NCI Community Oncology Research Program.	5UG1CA189973-11	Vanessa A. White, M.P.H.
Salman, Emad	Florida Assn Of Pediatric Tumor Prog United States	The Florida Pediatric NCORP renewal application for grant# UG1CA189973 to continue participation in the NCI Community Oncology Research Program.	5UG1CA189973-11	Vanessa A. White, M.P.H.
Salvemini, Daniela	Saint Louis University United States	A3AR agonists as a novel approach to mitigate chemotherapy induced neurotoxicity	5R01CA230512-05	Rachel Altshuler, Ph.D.
Salvemini, Daniela	Saint Louis University United States	A3AR agonists as a novel approach to mitigate chemotherapy induced neurotoxicity	5R01CA230512-05	Rachel Altshuler, Ph.D.
Salvemini, Daniela	Saint Louis University United States	Fingolimod and Ozanimod for the treatment and prevention of chemobrain	5R01CA261979-04	Rachel Altshuler, Ph.D.
Salvemini, Daniela	Saint Louis University United States	Fingolimod and Ozanimod for the treatment and prevention of chemobrain	5R01CA261979-04	Rachel Altshuler, Ph.D.
Sands, Stephen Alan	Sloan-Kettering Inst Can Research United States	Prospective international phase-III study to improve neurocognitive outcomes in young children with low-risk medulloblastoma (YCMB-LR)	5R01CA283045-02	Marjorie Perloff, M.D.
Sands, Stephen Alan	Sloan-Kettering Inst Can Research United States	Prospective international phase-III study to improve neurocognitive outcomes in young children with low-risk medulloblastoma (YCMB-LR)	5R01CA283045-02	Marjorie Perloff, M.D.